Author Correction to: Adjuvant Trastuzumab Therapy for Early HER2-Positive Breast Cancer in Iran: A Cost-Effectiveness and Scenario Analysis for an Optimal Treatment Strategy

AbstarctPage 95, Table  2, final row, second column: the mean Advanced treatment annual cost which
Source: PharmacoEconomics - Category: Health Management Source Type: research